Health News

Reviewing the Options for Treating MS
Multiple sclerosis (MS) symptoms vary widely among those with the disease. And that can complicate efforts to prescribe the right treatment for MS patients.
Rx Increased Viral Infection in MS Patients
Natalizumab is often used to fight the symptoms and progression of multiple sclerosis, but the drug comes with a significant risk of a rare and potentially fatal viral infection.
Smoking May Derail Effectiveness of MS Rx
Natalizumab (Tysabri) can decrease the disease activity and slow the disabling effects of relapsing-remitting multiple sclerosis, but smoking may change that.
Pregnancy and Multiple Sclerosis: Are Drugs Safe?
Living with a chronic disease can be difficult. Multiple sclerosis (MS), an autoimmune disease that affects the brain and spinal cord, is a condition that’s becoming easier to treat because of advances in medicine. Still, many women worry that the disease could prevent them from having children. MS occurs when the body’s immune system eats away at the protective sheath, called myelin, that covers nerves, which results in irreversible deterioration of the nerves. The condition is more common among women, especially women between the ages of 20 and 40 – during childbearing age. ...
Staying Able with Multiple Sclerosis
If you have been diagnosed with multiple sclerosis (MS), do not be disheartened. Even without a cure, there are drug treatments and other therapies that allow MS patients to continue living normal lives.
FDA Approves Safety Test for MS Drug
Tysabri , one of the few drugs approved to treat multiple sclerosis, is getting a label makeover courtesy of the FDA. The new look shows off a newly approved safety test for patients.
Avoiding Brain Infection for MS Patients
Multiple sclerosis does its damage in a patient's brain, and that's where most drugs are targeted. But one drug holds the dangerous risk of a severe brain infection for some patients.
MS: A Mysterious Malady
Multiple sclerosis (MS) is a puzzling disease. While scientists know little about the causes of MS, they know much more about its potentially debilitating effects.
FDA Drug Safety Communication: Tysabri
The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of progressive multifocal leukoencephalopathy ( PML ), a rare but serious brain infection, associated with use of Tysabri ( natalizumab ) for the treatment of multiple sclerosis (MS) and Crohn's disease.